Jerry Gin, P.h.D., MBA



Jerry Gin, Ph.D., MBA:

A Biography



Jerry has spent 50 years in health care, with focus on pharmaceuticals, diagnostics, biotechnology. He is also Chairman/CEO of the Foundation for Mind-Being Research, a non-profit organization focused in the area of science and consciousness. In 2006, Jerry co-founded and is President/CEO of Nuvora, a company with a sustained delivery platform for products to be delivered to the oral cavity. Its first products are for dry mouth and oral health. In 2003, Jerry co-founded Chakshu, which is now Livionex, where he is Chairman. Livionex has a platform technology for metal modulation with applications in treating inflammation and removing biofilm. Its first product is a dental gel that is more effective in cleaning teeth as well as reducing gingivitis. In the pipeline are gels and lotions which have applications for wounds, burns, diabetic leg edema, arthritis and an eye drop for improving vision in persons with cataracts. In1993, Jerry co-founded and was President/CEO of Oculex Pharmaceuticals and oversaw its successful start-up which eventually led to the acquisition by Allergan. The company developed the technology for controlled release delivery of drugs to the interior of the eye, specifically to treat macular edema. Prior to forming Oculex, Jerry co-founded his first company, ChemTrak, developers of the home cholesterol test commonly available in drug stores today. Jerry successfully took the company public and ventured on to form Oculex. Simultaneous to founding ChemTrak, Jerry co-founded Visionex, a company which developed the Schirmer Color Bar Tear Test for dry eyes and is currently sold to ophthalmologists. Jerry is currently also a Director for VistaGen Therapeutics, a public company in the space of central nervous system (CNS) disorders and diseases.

Prior to ChemTrak, Jerry was the Director of New Business Development and Strategic Planning for Syva, the diagnostic arm of Syntex Pharmaceuticals, Director for Pharmaceutical and Diagnostic businesses for Dow Chemical, and Director of Dow’s clinical laboratories (now known as Quest Laboratories).

Jerry received his B.S. in Chemistry from the University of Arizona, his Ph.D. in Biochemistry from the University of California, Berkeley, post-doctoral research at the National Institutes of Health, and his M.B.A. from Loyola College.